Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X

Your Partner Across Therapeutic Development and Manufacturing

From drug development and clinical research to commercial manufacturing and release testing, our Pharma Assay Development (PAD) technical experts can provide the 
end-to-end support needed to fuel your precision medicine and cell and gene therapy, through custom single-cell 
multi-omic analysis on the Tapestri platform.

TALK TO A SCIENTIST

Why Should Pharma Companies Use 
Pharma Assay Development (PAD) Services?

Rare cell detection, tracking clonal heterogeneity, and determining zygosity and co-occurence of edits at the single-cell level are all critical to the development and commercialization of personalized therapeutics. Partnering with PAD is the only solution to accessing these multi-parametric datasets on a single platform. Biopharmaceutical companies, both large and small, have leveraged PAD to advance their biomarker development, and cell and gene therapy pipelines.

Proof-of-concept study

Validate orthogonal data sets 

Targeted and custom assay design

Assay transfer to site/CRO/CDMO 

Streamline drug product release

Comprehensive Support Across 
the Pharma Workflow

Scope Project

Panel &
Assay Design

Wet Lab

Data Analysis

Long-term
Pipeline
Support

Panel &
Assay Design

8M

Cells analyzed on Tapestri in-house

15+

Novel custom assays developed and 
transfered to GMP

90

Publications world-wide from leading KOLs

45+

PAD and IND-enabling projects with Top Global 
Pharma partners

Explore PAD Services by Application

Cell and Gene 
Therapy

  • Validate gene editing platform for on- and off-target editing
  • Streamline vector copy number and transduction efficiency assays for 
drug lot release
  • Identify the right critical quality attributes (CQAs) to accelerate your path to clinic
LEARN MORE

Drug and Biomarker Development

  • Recapitulate and validate disease in humanized models
  • Uncover molecular resistance mechanisms to improve patient stratification
  • Reveal complex clonal architectures of 
co-occurring mutations
  • Understand clonal phylogeny and selection for lineage tracing and response to drug treatment
  • Integrate single-cell genotypic and immunophenotypic information to predict relapse on remission samples.
LEARN MORE

Custom Solutions

If you don’t see an application that fits your needs, ask us about developing a custom solution. To date, we have produced 15 fit-for-purpose assays, with more on the way.

Developing Custom Assays for Leading Companies

Get Started

Contact us to begin your evaluation
CONTACT US
REQUEST QUOTE